Consensus report from the Miami Liver Proton Therapy Conference Review


Authors: Chuong, M. D.; Kaiser, A.; Khan, F.; Parikh, P.; Ben-Josef, E.; Crane, C.; Brunner, T.; Okumura, T.; Schreuder, N.; Bentzen, S. M.; Gutierrez, A.; Romero, A. M.; Yoon, S. M.; Sharma, N.; Kim, T. H.; Kishi, K.; Moeslein, F.; Hoffe, S.; Schefter, T.; Hanish, S.; Scorsetti, M.; Apisarnthanarax, S.
Review Title: Consensus report from the Miami Liver Proton Therapy Conference
Abstract: An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed. © 2007 - 2019 Frontiers Media S.A. All Rights Reserved.
Keywords: liver cancer; liver metastases; proton therapy; hepatocellular carcinoma (hcc); cholangiocarcinoma (cc)
Journal Title: Frontiers in Oncology
Volume: 9
ISSN: 2234-943X
Publisher: Frontiers Media S.A.  
Date Published: 2019-05-31
Start Page: 457
Language: English
DOI: 10.3389/fonc.2019.00457
PROVIDER: scopus
PMCID: PMC6557299
PUBMED: 31214502
DOI/URL:
Notes: Review -- Export Date: 2 August 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christopher   Crane
    201 Crane